GSN and amyloidosis: The gelsolin amyloidosis patients with the Finnish mutation will experience a triad of ophthalmological, neurological and dermal symptoms as a cause of gelsolin fragment accumulation in the basement membrane of the skin, blood vessel walls, eyes and peripheral nervous system [2].